Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Cardiovascular Implants Market from 2024 to 2025?

Intense expansion has been witnessed in the cardiovascular implants industry in the past few years. The market, anticipated to climb from $26.8 billion in 2024 to $28.86 billion in 2025, will have a compound annual growth rate (CAGR) of 7.7%. The historic growth trend is primarily due to factors such as an increase in the elderly population and cardiovascular risks, lifestyle-associated cardiovascular risk aspects, advancements in diagnostic technologies, heightened consciousness and screening initiatives, as well as governmental schemes aimed at cardiovascular health.

What Is the Projected Market Size of the Cardiovascular Implants Market?

Strong growth is anticipated in the cardiovascular implants market size in the coming years, with it anticipated to reach a value of $36.69 billion by 2029, expanding at a compound annual growth rate (CAGR) of 6.2%. This growth during the prediction period can be credited to factors such as the adoption of personalized medicine techniques, the preference for minimally invasive procedures, global cooperation on cardiovascular research, health policies that emphasize preventive measures, and patient-focused cardiovascular care. Major predicted developments include progress in drug-eluting stents, the emergence of next-generation heart valves, an increase in the integration of artificial intelligence (AI), a focus on minimally invasive implant deployment techniques, personalized and patient-specific implants, and the development of leadless pacemakers.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13399&type=smp

Who are the Major Competitors in the Cardiovascular Implants Market Outlook?

Major companies operating in the cardiovascular implants market report are Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, B. Braun Melsungen AG, Edwards Lifesciences Corporation, W. L. Gore & Associates Inc., Cook Medical Incorporated, Teleflex Incorporated, Kyoto Medical Planning Co. Ltd., Abiomed Inc., Livanova PLC, BIOTRONIK SE & Co. KG, CryoLife Inc., Endologix Inc., Sorin Group, Berlin Heart GmbH, REVA Medical LLC., Syncardia Systems LLC, Elixir Medical Corporation, Fortimedix Surgical B.V., AMG International GmbH, CHF Solutions Inc., Proxy Biomedical Ltd., Calon Cardio-Technology Ltd., InspireMD Inc., Neovasc Inc., Shree Pacetronix Ltd., Vascutek Ltd (Terumo Corporation)

What Is Fueling Growth in the Cardiovascular Implants Market?

The anticipated increase in heart disorders is set to trigger expansion in the cardiovascular implants market. Heart disorders, this term signifies a host of medical ailments that afflict the heart and blood vessels, like coronary artery disease, heart failure, arrhythmias, and valve problems. The prevalence of heart illnesses like coronary artery disease and heart failure has accelerated the need for cardiovascular implants such as stents and pacemakers to treat these conditions. These implants aid in heart and circulation functions in heart failure patients, ensure a regular heart rhythm and monitor heart rhythm. For example, the British Heart Foundation (BHF), reported in September 2024 that approximately 7.6 million individuals in the UK are suffering from heart and circulatory disorders. The estimation is that by 2030, the population living with heart and circulatory diseases in the UK could surge by 1 million, and by 2040, it may soar by 2 million. Hence, the upcoming risk of heart disorders is bolstering the cardiovascular implants market.

Cardiovascular Implants Market Driver: Advancement in Cardiovascular Implant Market Sparked by Growing Aged Population

 

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=13399&type=smp

Which Cardiovascular Implants Market Segments Are Growing the Fastest?

The cardiovascular implants market covered in this report is segmented –

1) By Product: Coronary Stent, Implantable Cardioverter Defibrillator (ICD), Heart Valve, Implanted Cardiac Pacemaker, Cardiac Resynchronization Therapy (CRT) Devices, Peripheral Stent

2) By Material: Metals and Alloys, Polymers, Biological Materials

3) By Application: Arrhythmias, Acute Myocardial Infarction, Myocardial Ischemia, Other Applications

4) By End-Users: Hospitals, Ambulatory Surgical Centers, Cardiac Centers

Subsegments:

1) By Coronary Stent: Drug-Eluting Stents, Bare-Metal Stents, Bioabsorbable Stents

2) By Implantable Cardioverter Defibrillator (ICD): Single-Chamber ICD, Dual-Chamber ICD, Biventricular ICD

3) By Heart Valve: Mechanical Heart Valves, Biological Heart Valves, Transcatheter Heart Valves

4) By Implanted Cardiac Pacemaker: Single-Chamber Pacemaker, Dual-Chamber Pacemaker, Biventricular Pacemaker

5) By Cardiac Resynchronization Therapy (CRT) Devices: CRT-P Devices (Pacemakers), CRT-D Devices (Defibrillators)

6) By Peripheral Stent: Carotid Artery Stents, Renal Artery Stents, Femoral Artery Stents

Which Industry Trends Are Shaping the Future of the Cardiovascular Implants Market?

Leading enterprises in the cardiovascular implants market are directing their efforts towards the integration of advanced technology and artificial intelligence (AI) to optimize their market profits and improve patient care and treatment accuracy. The evolution of cardiac monitoring technology now involves consistent tracking and recording of a patient’s cardiac activity for precise diagnosis and management of heart conditions. For instance, BIOTRONIK SE & Co. KG, a medical technology firm based in Germany, rolled out the global implantation of its BIOMONITOR IV, implantable cardiac monitor (ICM), in June 2023. The state-of-the-art ICM, BIOMONITOR IV encompasses BIOTRONIK’s SmartECG technology and AI, leading to an 86% reduction in false-positive detections while maintaining 98% of genuine episodes. The BIOMONITOR IV extends several other benefits to patients and healthcare professionals apart from the nuanced AI; its long battery life and wireless connectivity facilitate seamless data transmission and remote monitoring, thereby diminishing the requirement for regular in-person clinic appointments.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/cardiovascular-implants-global-market-report

Which Countries Are Leading the Cardiovascular Implants Market?

North America was the largest region in the cardiovascular implants market in 2024. The regions covered in the cardiovascular implants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13399

This Report Delivers Insight On:

1. How big is the cardiovascular implants market, and how is it changing globally?

2. Who are the major companies in the cardiovascular implants market, and how are they performing?

3. What are the key opportunities and risks in the cardiovascular implants market right now?

4. Which products or customer segments are growing the most in the cardiovascular implants market?

5. What factors are helping or slowing down the growth of the cardiovascular implants market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

[KClientError] [REQ_ERR: OPERATION_TIMEDOUT] [KTrafficClient] Something is wrong.